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Summary
To improve our ability to identify hematopoietic stem
cells (HSCs) and their localization in vivo, we com-
pared the gene expression profiles of highly purified
HSCs and non-self-renewing multipotent hematopoi-
etic progenitors (MPPs). Cell surface receptors of the
SLAM family, including CD150, CD244, and CD48,
were differentially expressed among functionally dis-
tinct progenitors. HSCs were highly purified as
CD150+CD244−CD48− cells while MPPs were CD244+
CD150−CD48− and most restricted progenitors were
CD48+CD244+CD150−. The primitiveness of hemato-
poietic progenitors could thus be predicted based on
the combination of SLAM family members they ex-
pressed. This is the first family of receptors whose
combinatorial expression precisely distinguishes
stem and progenitor cells. The ability to purify HSCs
based on a simple combination of SLAM receptors
allowed us to identify HSCs in tissue sections. Many
HSCs were associated with sinusoidal endothelium in
spleen and bone marrow, though some HSCs were
associated with endosteum. HSCs thus occupy multi-
ple niches, including sinusoidal endothelium in di-
verse tissues.
Introduction
Two central and related questions in stem cell biology
involve the identification of markers that distinguish
stem cells from other progenitors and the identification
of microenvironments (“niches”) in which stem cells re-
side (Morrison et al., 1997a; Spradling et al., 2001).
These issues have been studied extensively in the
hematopoietic system (Lemischka, 1997; Phillips et al.,
2000; Hackney et al., 2002; Ivanova et al., 2002; Ra-
malho-Santos et al., 2002), but our inability to rigor-
ously identify HSCs using simple combinations of
markers has compromised our ability to study HSC mi-
croenvironments in vivo.
The locations and identities of differentiated cells are
often defined by the differential expression of individual*Correspondence: seanjm@umich.edu
3 These authors contributed equally to this work.families of cell surface receptors. The locations and
identities of olfactory sensory neurons and chemosen-
sory neurons are distinguished by their differential ex-
pression of olfactory receptors (Buck and Axel, 1991)
and Mrg family receptors (Dong et al., 2001), respec-
tively. Although the gene expression profiles of multiple
stem cell populations have been described (Ivanova et
al., 2002; Ramalho-Santos et al., 2002; Easterday et al.,
2003; Evsikov and Solter, 2003; Fortunel et al., 2003;
Iwashita et al., 2003), no single family of cell surface
receptors has yet been found in which members are
differentially expressed in a way that correlates with
primitiveness or developmental potential.
In the absence of simple combinations of markers
that reliably purify HSCs, it has been necessary to use
complex combinations of markers. HSCs have been
highly enriched as Thy-1loSca-1+Lineage−c-kit+ cells or
CD34−Sca-1+Lineage−c-kit+ cells using combinations
of 10–12 surface markers (Spangrude et al., 1988; Mor-
rison and Weissman, 1994; Osawa et al., 1996). But
even using these complicated sets of markers, only
20% of intravenously injected cells gave long-term
multilineage reconstitution in most studies (Morrison et
al., 1995; Spangrude et al., 1995; Osawa et al., 1996;
Wagers et al., 2002). By gating more restrictively on ex-
isting HSC markers, or by combining these with
Hoechst exclusion, nearly homogeneous subsets of
bone marrow HSCs have been isolated (Uchida et al.,
2003; Matsuzaki et al., 2004; Takano et al., 2004), but
these markers remain too complex for the identification
of HSCs in tissue sections.
Studies of various transgenic mice have demon-
strated the functional importance of osteoblasts in reg-
ulating bone marrow HSCs (Calvi et al., 2003; Zhang
et al., 2003; Visnjic et al., 2004). Immunofluorescence
studies with markers of primitive hematopoietic pro-
genitors have suggested that HSCs interact with osteo-
blasts at the endosteum of bone marrow (Zhang et al.,
2003; Arai et al., 2004; Wilson et al., 2004). However,
not all HSCs can be associated with osteoblasts. The
ability of cytokines to mobilize HSCs into circulation
within minutes (Laterveer et al., 1995) has suggested
that a subset of HSCs must be closely associated with
blood vessels in the bone marrow (Heissig et al., 2002).
Moreover, there are no osteoblasts in sites of ex-
tramedullary hematopoiesis, like the liver and spleen,
where HSCs are maintained throughout adult life (Tani-
guchi et al., 1996). These observations indicate that the
endosteum/osteoblast microenvironment is unlikely to
be the sole supportive niche for HSCs.
Endothelial cells also regulate HSC function and
could contribute to the creation of HSC niches. Endo-
thelial cells are capable of maintaining HSCs in culture
(Cardier and Barbera-Guillem, 1997; Ohneda et al.,
1998; Li et al., 2004), and ablation of endothelial cells
in vivo by administration of anti-VE-cadherin antibody
leads to hematopoietic failure (Avecilla et al., 2004). En-
dothelial cells also create stem cell niches in other tis-
sues such as the nervous system (Palmer et al., 2000;
Capela and Temple, 2002; Louissaint et al., 2002; Shen
Cell
1110et al., 2004). Simple combinations of markers that iden- e
(tify HSCs with high reliability would make it possible to
test whether HSCs interact with endothelial cells in vivo. C
(We have found that SLAM family receptors are dif-
ferentially expressed among hematopoietic progenitors e
sin a way that correlates with progenitor primitiveness.
The SLAM family is a group of 10–11 cell surface recep-
ators that are tandemly arrayed at a single locus on chro-
mosome 1 (Engel et al., 2003; Sidorenko and Clark, t
c2003). SLAM family members regulate the proliferation
and activation of lymphocytes (Howie et al., 2002; (
tWang et al., 2004). Our ability to purify HSCs using sim-
ple combinations of SLAM family members made it H
ipossible to image HSCs in tissue sections using mark-
ers that had been validated as yielding high HSC purity s
ein functional assays. Many HSCs within the bone mar-
row and spleen were associated with sinusoidal endo- b
athelium. This reveals the importance of sinusoidal en-
dothelial cells for the localization of HSCs throughout q
dhematopoietic tissues.
c
cResults
p
tThe Purity of Cells Used for Gene
Expression Profiling
To identify genes that are tightly associated with HSC
Cidentity, we have compared the gene expression pro-
Ofiles of highly enriched populations of HSCs and tran-
rsiently reconstituting multipotent progenitors (MPPs)
t(Morrison and Weissman, 1994; Morrison et al., 1997b).
pThe quality of gene expression profiles depends upon
tthe purity of cells used. HSCs were isolated as Thy-
21loSca-1+Lineage−c-kit+ cells. One out of every 4.9 ± 2.5
b(20%) intravenously injected Thy-1loSca-1+Lineage−c-
Mkit+ cells long-term multilineage reconstituted irradi-
aated mice in limit dilution competitive reconstitution as-
wsays (see Table S1 in the Supplemental Data available
mwith this article online).
aThy-1loSca-1+Lineage−c-kit+ HSCs give rise to non-
4self-renewing Thy-1loSca-1+Mac-1loCD4lo MPPs in vivo
k(Morrison et al., 1997b). We have enhanced the purity
tof this cell population by further selecting the B220−
(subset of Thy-1loSca-1+Mac-1loCD4lo cells (Table S2).
One out of every 4.0 intravenously injected Thy-1loSca-
f1+Mac-1loCD4loB220− cells (25%) reconstituted irradi-
Cated mice in competitive reconstitution assays, usually
tgiving transient multilineage reconstitution (Table S2).
wThy-1loSca-1+Mac-1loCD4loB220− cells are more highly
benriched for MPPs than any previously characterized
dcell population.
l
oGenes that Are Tightly Linked to HSC Identity
aWe isolated three independent 5000 cell aliquots of
eHSCs or MPPs or 8000 CD45+ bone marrow cells
m(which include nearly all hematopoietic cells; more of
Hthese cells were used because they have a lower RNA
icontent) and independently extracted and amplified
oRNA from each aliquot for gene expression profiling
t(Iwashita et al., 2003). The gene expression profiles
twere compared using Affymetrix oligonucleotide arrays
c(Tables S3 and S4). Variability was low among samples
tof the same type: Pearson correlation coefficient, R2 =
0.988 to 0.991 for untransformed data (Table S4). How- iver, the variability between samples of different types
HSC versus MPP, R2 = 0.798 ± 0.024; HSC versus
D45+, R2 = 0.558 ± 0.009) was significantly higher
p < 0.0005). Transcript expression was detected (pres-
nt calls) at 46% of probe sets for HSCs, 46% of probe
ets for MPPs, and 41% of probe sets for CD45+ cells.
We identified genes for which signal intensities were
t least 3-fold higher in HSCs, the difference was statis-
ically significant (p < 0.05), and signals were signifi-
antly above background in at least one HSC sample
nonzero present call). We identified 1151 probe sets
hat satisfied these criteria for being upregulated in
SCs as compared to CD45+ cells, and 46 probe sets
n HSCs as compared to MPPs (out of 36,701 probe
ets total). Twenty-seven of these 46 probe sets were
xpressed at higher levels in HSCs as compared to
oth MPPs and CD45+ cells (Table 1). To further evalu-
te these genes, we compared their expression by
uantitative (real-time) RT-PCR in at least two indepen-
ent samples of HSCs, MPPs, and whole bone marrow
ells. Of the 25 genes against which qPCR primers
ould be designed, all were confirmed as being ex-
ressed at >1.9-fold higher levels in HSCs as compared
o MPPs and CD45+ cells (Table 1).
D150 Is Expressed by HSCs but Not by MPPs
ne of these genes encodes the homotypic cell surface
eceptor CD150 (SLAM), which was not previously iden-
ified as being expressed in stem cells or other hemato-
oietic progenitors. CD150 is the founding member of
he SLAM family of cell surface receptors (Engel et al.,
003; Sidorenko and Clark, 2003). CD150 appeared to
e 4- to 17-fold upregulated in HSCs as compared to
PPs and CD45+ bone marrow cells by microarray
nalysis and qPCR (Table 1). Only 6.6% ± 1.7% of
hole bone marrow cells were CD150+ by flow cyto-
etry (Figure 1A). Consistent with the trends observed
t the RNA level (Table 1), CD150 was expressed by
6% ± 12% of cells within the Thy-1loSca-1+Lineage−c-
it+ HSC population but by only 0.9% ± 0.5% of cells in
he Thy-1loSca-1+Mac-1loCD4loB220− MPP population
Figures 1B and 1C).
To test whether CD150+ cells include HSCs, we per-
ormed competitive reconstitution assays in which
D150+ or CD150− donor bone marrow cells were
ransplanted into lethally irradiated recipient mice along
ith a radioprotective dose of recipient-type whole
one marrow cells (Figure 1D). In each of two indepen-
ent experiments, recipients of the CD150+ cells were
ong-term multilineage reconstituted by donor cells (six
f six mice), while recipients of CD150− cells almost
lways (eight of nine mice) exhibited transient multilin-
age reconstitution (one of nine mice was long-term
ultilineage reconstituted). These data indicate that
SCs are enriched in the CD150+ fraction and depleted
n the CD150− fraction of bone marrow cells. Recipients
f CD150+ bone marrow cells were always able to
ransfer long-term multilineage donor cell reconstitu-
ion to secondary recipients, while recipients of CD150−
ells were not able to transfer donor cell reconstitution
o secondary recipients (data not shown). These results
dentify CD150 as a new marker of HSCs.
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1111Table 1. Genes that Were Expressed at Higher Levels in HSCs as Compared to MPPs and CD45+ Cells by Both Microarray Analysis and
Quantitative PCR
Microarray qPCR
GenBank HSC/ HSC/
Gene Symbol Unigene Title Accession MPP HSC/CD45+ MPP HSC/WBM
Clca1 Chloride channel calcium activated 1 AF047838 8.3 9.1 32.8 3.3
Cpne8 Copine VIII AV240111 7.0 11.0 3.8 29.9
Sdpr Serum deprivation response AI839175 7.0 7.0 116.7 40.3
Catnal1 Catenin alpha-like 1 AI152317 6.9 8.8 4.0 26.2
Prkcm Protein kinase C mu AV297026 6.4 7.0 ND ND
Vwf Von Willebrand factor homolog AI843063 6.2 17.2 5.2 4.2
Est RIKEN full-length library, clone:E330020H17 AI853427 5.7 5.7 4.9 2.8
Mjd Machado-Joseph disease homolog AV262417 5.2 5.9 1.9 2.3
Ly64 Lymphocyte antigen 64 AV204260 4.8 13.7 9.0 53.8
D10Ertd755e DNA segment, Chr 10, ERATO Doi 755, AU019706 4.7 4.7 ND ND
expressed
C530008M17Rik RIKEN cDNA C530008M17 gene AI851362 4.7 7.4 15.3 2.9
Est Mus musculus transcribed sequences AI666656 4.1 10.7 1.9 2.8
Slam Signaling lymphocyte activation molecule AI120008 4.0 4.0 5.8 17.0
Est Mus musculus transcribed sequences AV236645 3.6 9.7 5.6 7.0
Rnf125 Ring finger protein 125 AV361188 3.6 6.0 2.4 2.9
Peg12 Paternally expressed 12 AI413890 3.6 3.8 9.2 22.9
Bgn Biglycan AV016619 3.5 64.1 7.7 52.6
Exosc1 Exosome component 1 AI592141 3.4 7.8 2.5 2.6
Stub1 STIP1 homology and U-box containing protein 1 AW046544 3.4 5.0 2.5 2.2
Gemin4 Gem (nuclear organelle)-associated protein 4 AV341751 3.4 5.4 2.8 5.9
Tfpi Tissue factor pathway inhibitor AI480514 3.2 4.9 4.6 9.2
Est Mus musculus transcribed sequences AI482323 3.2 16.9 3.4 10.2
pbx1 Pre-B cell leukemia transcription factor 1 AI845678 3.1 4.3 3.5 15.6
Sdsl Serine dehydratase-like AI504310 3.1 14.7 7.0 6.1
Ppap2b Phosphatidic acid phosphatase type 2B AV346092 3.1 3.7 2.5 2.9
Armcx1 Armadillo repeat-containing, X-linked 1 AI846227 3.0 3.1 5.6 34.0
Phactr2 Phosphatase and actin regulator 2 AW123926 3.0 4.0 1.9 3.0
cRNA from Thy-1loSca-1+Lineage−c-kit+ HSCs, Thy-1loSca-1+Mac-1loCD4loB220− MPPs, or CD45+ bone marrow cells were hybridized to
oligonucleotide arrays. The average untransformed probe intensities from three independent samples were used to calculate fold change
(HSC/MPP; HSC/CD45+). The table lists all of the genes that were expressed at significantly higher levels in HSCs as compared to MPPs and
CD45+ cells by both microarray analysis (fold change >3.0) and quantitative (real-time) PCR (fold change >1.9).CD244 Is Expressed by Transiently Reconstituting
MPPs but Not by HSCs
To test whether other SLAM family members might be
differentially expressed between hematopoietic pro-
genitors, we examined the SLAM family member
CD244, which was not detected in HSCs by microarray
analysis (Table S1). At the protein level, only 8.9% ±
0.6% of bone marrow cells expressed CD244 by flow
cytometry (Figure 2A). Little or no CD244 staining was
detected among Thy-1loSca-1+Lineage−c-kit+ HSCs
(Figure 2B), but 33% ± 10% of cells in the Thy-1loSca-
1+Mac-1loCD4lo MPP population were CD244+ (Figure
2C). This suggested that at least some MPPs ex-
pressed CD244.
We performed two independent competitive recon-
stitution assays in which CD244+ or CD244− donor
bone marrow cells were transplanted into lethally irradi-
ated recipient mice along with a radioprotective dose
of recipient-type whole bone marrow cells (Figure 2D).
Recipients of the CD244− cells were always long-term
multilineage reconstituted by donor cells (eight of eight
mice), while recipients of the CD244+ cells were always
transiently multilineage reconstituted (eight of eight
mice). Consistent with this, recipients of CD244− cells
were always able to transfer long-term multilineage re-
constitution to secondary recipients, while recipients of
CD244+ cells were never able to transfer donor cell re-constitution to secondary recipients (data not shown;
transplants were performed 16 weeks after reconstitu-
tion of primary recipients). These data indicate that
HSCs are contained within the CD244− fraction, while
at least some transiently reconstituting MPPs are con-
tained within the CD244+ fraction of bone marrow cells.
CD48 Is Expressed by Restricted Progenitors
but Not by HSCs or MPPs
By microarray analysis (Table S3), the SLAM family
member CD48 was expressed at significantly higher
levels on CD45+ cells as compared to HSCs or MPPs
(fold change >3). CD48 is a ligand for CD244 (Engel et
al., 2003). To test whether CD48+ cells were depleted of
HSC activity, we performed competitive reconstitution
assays in which CD48+ or CD48− donor bone marrow
cells were transplanted into lethally irradiated recipient
mice along with a radioprotective dose of recipient-
type whole bone marrow cells (Figure 3). Recipients of
the CD48− cells were always long-term multilineage re-
constituted by donor cells (five of five mice), while re-
cipients of the CD48+ cells were always reconstituted
by B cells (six of six mice) but never by myeloid cells
(zero of six) and rarely by T cells (one of six). These
data indicate that CD48+ cells include restricted B cell
progenitors but that all HSCs and MPPs are CD48−.
Although CD48 was not expressed by multipotent
Cell
1112Figure 1. CD150+ Cells Are Enriched for
HSCs while CD150− Cells Include Transiently
Reconstituting MPPs
Only 6.6% of bone marrow cells express
CD150 (A). CD150 expression was detected
among Thy-1loSca-1+Lineage−c-kit+ HSCs
(B) but not among Thy-1loSca-1+Mac-
1loCD4loB220− MPPs (C). CD150+ bone mar-
row cells (20,000) gave rise to long-term
multilineage reconstitution in all recipients
(D, blue lines), while 180,000 CD150− bone
marrow cells gave transient multilineage re-
constitution (D, red lines). Cell doses were
based on the fraction of 200,000 whole bone
marrow cells that were CD150+ or CD150−
as in prior HSC marker studies (Uchida and
Weissman, 1992; Morrison et al., 1995). The
black line at 0.3% represents the back-
ground threshold, meaning that reconstitu-
tion could not be detected in mice falling be-
low this line. Data are from one of two
independent experiments that gave similar
results. Each line represents the frequency
of donor-derived myeloid, B, or T cells in a
single mouse.progenitors, it was expressed by most progenitors that t
(formed myeloerythroid colonies in culture in addition to
lB lineage progenitors (Figures 3D and 3E). Of all col-
sony-forming progenitors from bone marrow, 83.4% ±
r3.7% fell within the CD48+CD244+CD150− population,
which accounts for only 5.1% ± 0.4% of bone marrow
wcells (Figure 3E). Some additional erythroid (BFU-E) and
rmegakaryocyte (CFU-Meg) progenitors fell within the
tCD48+CD244−CD150− population (Figure 3E). While
1CD150 is expressed by HSCs and CD244 is expressed
(by transiently reconstituting MPPs, most colony-form-
cing progenitors express CD48. Each of these markers
Cis thus expressed at a different stage of the hematopoi-
wesis hierarchy.
a
f
A SLAM Code for Hematopoietic Stem Cells i
These results raised the possibility that HSCs and other s
progenitors could be isolated based on combinations o
of SLAM family members. HSC activity was contained c
in the CD150+ but rarely in the CD150− fraction (Figure r
1D), the CD244− but not the CD244+ fraction (Figure 1
2D), and the CD48− but not the CD48+ fraction (Fig- l
ure 3D). The CD150+CD48−CD244− fraction of bone T
marrow cells represented only 0.0084% ± 0.0028% of i
whole bone marrow cells. Since CD150+CD48− cells p
were uniformly CD244− (Figures 4A and 4B), we tested
the reconstituting potential of CD150+CD48− cells. On H
average, one out of every 4.8 ± 2.7 (21%) injected cells a
engrafted and yielded long-term multilineage reconsti- O
tution (Figure 4C; Table S5). These results are similar tohose obtained with Thy-1loSca-1+Lineage−c-kit+ cells
one in 4.9 ± 2.5 engrafted and yielded long-term multi-
ineage reconstitution; Table S1), indicating that the
imple combination of CD150 and CD48 can highly en-
ich HSCs.
To test whether the combination of CD150 and CD48
ith other markers might yield an even more highly en-
iched population of HSCs, we competitively reconsti-
uted irradiated mice with single CD150+CD48−Sca-
+Lineage−c-kit+ cells in five independent experiments
Table 2). Only 0.0058% ± 0.0012% of bone marrow
ells were CD150+CD48−Sca-1+Lineage−c-kit+. One
D150+CD48−Sca-1+Lineage−c-kit+ cell was sorted per
ell, and then the contents of each well were individu-
lly injected into the recipient mice. We visually con-
irmed the presence of a single cell per well prior to
njection and functionally confirmed the presence of a
ingle cell per well in control studies (Figure S1). One
ut of every 2.1 CD150+CD48−Sca-1+Lineage−c-kit+
ells (47%) engrafted and gave long-term multilineage
econstitution. In contrast, the CD150− subset of Thy-
loSca-1+Lineage−c-kit+ cells (Figure 1B) did not give
ong-term multilineage reconstitution (data not shown).
he combination of CD150 and CD48 with previously
dentified HSC markers significantly increased HSC
urity.
SC SLAM Receptor Expression Is Conserved
mong Mouse Strains
ne impediment in the identification of HSCs is thatsome of the best markers, including Thy-1 and Sca-1,
SLAM Receptors Identify Stem Cells and Niches
1113Figure 2. HSCs Are CD244− while Transiently
Reconstituting Multipotent Progenitors Are
CD244+
Only 8.9% of bone marrow cells express
CD244 (A). CD244 expression was not de-
tected within the Thy-1loSca-1+Lineage−c-
kit+ HSC population (B) but was detected on
approximately 33% of Thy-1loSca-1+Mac-
1loCD4loB220− MPPs (C). Note that the black
histogram represents background fluores-
cence, while the blue histogram represents
staining with the directly conjugated anti-
CD244 antibody. CD244+ bone marrow cells
(20,000) gave transient multilineage reconsti-
tution in all recipients (blue lines), while
180,000 CD244− bone marrow cells gave
long-term multilineage reconstitution in all
recipients (red lines). The data are from one
of two independent experiments that gave
similar results.are not conserved among mouse strains (Spangrude
and Brooks, 1992; Spangrude and Brooks, 1993). To
test whether the HSC SLAM markers are conserved
among mouse strains, we isolated CD150+CD48− cells
from the bone marrow of Balb/c and DBA/2 mice, which
arise from distinct breeding lineages as compared to
C57BL mice (Jackson Laboratory, 1997). CD150+CD48−
cells were rare in Balb/c and DBA/2 mice, representing
0.016% ± 0.002% or 0.028% ± 0.007% of bone marrow
cells, respectively (Figures 5A and 5B). While Balb/c
mice have a similar frequency of HSCs in their bone
marrow as C57BL mice, DBA/2 mice have a 2- to 3-fold
increase in HSC frequency (deHaan et al., 1997).
Ten male CD150+CD48− cells from either strain were
injected into lethally irradiated female recipients, along
with a radioprotective dose of 200,000 female bone
marrow cells. Blood chimerism was tested by quantita-
tive (real-time) PCR using primers that amplify SRY, a Y
chromosome (donor) marker. Sixteen weeks after trans-
plantation, 11 out of 16 Balb/c recipients were reconsti-
tuted (>1.5%) by male cells, averaging 10.8% ± 14.3%
of blood cells (Figure 5E). Seven out of 15 DBA/2 recipi-
ents were clearly reconstituted (>0.6%) by male cells,
averaging 3.5% ± 3.8% of blood cells (Figure 5F).
Lower levels of DBA/2 reconstitution were expected,
given that DBA/2 mice have more competing HSCs in
cotransplanted female bone marrow. Two additional
DBA/2 mice exhibited very low levels of male cells
(w0.2%) and were not considered HSC reconstituted.
To confirm that these mice exhibited multilineage re-
constitution, three reconstituted mice and one unre-
constituted mouse from each strain were sacrificed,and myeloid (Mac-1+B220−CD3−), B (B220+CD3−Mac-
1−), and T (CD3+Mac-1−B220−) cells were isolated from
their spleens. In each case, the reconstituted mice had
male cells in all three lineages, while the unreconstitu-
ted mice did not (Figures 5E and 5F). These results cor-
respond to 1 out of 9.1 Balb/c CD150+CD48− cells
(11%) and 1 out of 16.4 DBA CD150+CD48− cells (6%)
giving long-term multilineage reconstitution. HSCs from
Balb/c and DBA/2 mice are also highly enriched within
the CD150+CD48− population.
Identifying HSCs using Simple Markers that Yield
High Purity in Functional Assays
One out of 4.8 (21%) CD150+CD48− cells from C57BL
mice gave long-term multilineage reconstitution (Figure
4, Table S5). This raised the possibility of identifying
HSCs in tissue sections using a simple two-color stain.
Initial studies revealed that a subset of megakaryocytes
also appeared CD150+CD48− in sections (data not
shown), partially explaining why not every CD150+CD48−
cell gave long-term multilineage reconstitution. To en-
hance our ability to reliably identify HSCs in tissue
sections, we sought an additional marker that would
distinguish HSCs from megakaryocytes. CD41 is a
commonly used marker of megakaryocyte lineage cells
(Phillips et al., 1988; Na Nakorn et al., 2003). Although
CD41 is expressed by primitive HSCs, CD41 is down-
regulated by HSCs during the transition to definitive he-
matopoiesis, and most adult HSCs do not express
CD41 (Ferkowicz et al., 2003; Mikkola et al., 2003). By
flow cytometry, 37% ± 5% of CD150+CD48− cells were
CD41+ (Figure S2A), and megakaryocytes (which can
Cell
1114Figure 3. HSCs and MPPs Are Contained
within the CD48− Fraction while Colony-
Forming Progenitors Are Mainly in the CD48+
Fraction of Bone Marrow Cells
Forty-three percent of bone marrow cells ex-
press CD48 (A). CD48 expression was de-
tected in the Thy-1loSca-1+Lineage−c-kit+
HSC population (B) but not in Thy-1loSca-
1+Mac-1loCD4loB220− MPPs (C). All multilin-
eage reconstituting activity was contained
within the CD48− cell fraction (D). CD48+
bone marrow cells (80,000) gave rise only to
B cells in all recipients (blue lines), while
120,000 CD48− bone marrow cells gave
long-term multilineage reconstitution in all
recipients (red lines). CD48−c-kit+ cells are
highly enriched for HSCs but are not visible
in (A) because they represent only 0.1% of
bone marrow cells. The vast majority of bone
marrow cells that formed myeloerythroid colo-
nies in methylcellulose were CD48+CD244+
CD150− (E). Each bar represents the percen-
tage of total colony-forming progenitors
from unfractionated bone marrow that are
contained within the given cell population.
For example, 83.4% of all colonies (CFU-C,
white bar) formed by bone marrow cells orig-
inate from the CD48+CD244+CD150− pop-
ulation.be recognized by their unique size and morphology) a
±were excluded when sections were examined for
CD150+CD48−CD41− cells (Figure 6C). The exclusion of a
oCD41+ cells thus further enhances the purity of CD150+
CD48− HSCs. (
2To confirm that adult HSCs were CD41−, even in ex-
tramedullary tissues, we sorted CD41+ and CD41− cells f
tfrom the spleen after cyclophosphamide/G-CSF treat-
ment (Figure S2B). Cyclophosphamide/G-CSF treat- i
1ment leads to the mobilization of HSCs from the bone
marrow, increasing the frequency of HSCs in the spleen c
(Morrison et al., 1997c). While CD41− cells always (five
of five) gave long-term multilineage reconstitution in re- E
wcipient mice, we never (zero of five) detected reconsti-
tution from CD41+ cells (Figure S2C). Adult HSCs do P
hnot express detectable CD41 in mobilized spleen, con-
sistent with previous studies of adult bone marrow. o
2To test the purity of CD150+CD48−CD41− cells, we
isolated this population from normal bone marrow s
n(where they represented 0.0065% ± 0.0009% of cells)nd mobilized spleen (where they represented 0.0063%
0.0005% of cells), and injected single cells into irradi-
ted mice in competitive reconstitution assays. One out
f every 2.2 bone marrow CD150+CD48−CD41− cells
45%) gave long-term multilineage reconstitution (Table
). One out of every three CD150+CD48−CD41− cells
rom mobilized spleen (33%; four of 12 mice) gave long-
erm multilineage reconstitution (Table 2), a dramatic
ncrease in purity relative to mobilized Thy-1loSca-
+Lineage−c-kit+ cells (Morrison et al., 1997c). This two-
olor stain thus simplifies and improves HSC isolation.
xtramedullary HSCs Associate
ith Sinusoidal Endothelium
rior studies have imaged the interaction of primitive
ematopoietic progenitors with osteoblasts in the end-
steum of bone marrow (Zhang et al., 2003; Arai et al.,
004; Wilson et al., 2004) (see Figures S2D and S2E for
chematic of bone marrow and spleen), but HSCs have
ot been imaged in sites of extramedullary hematopoi-
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1115Figure 4. CD150+CD48−CD244− Cells Are Highly Enriched for Long-
Term Reconstituting HSCs
CD150+CD48− cells represented only 0.0084% of bone marrow
cells (A), and these cells were uniformly negative for CD244 expres-
sion (B). Injection of three donor-type CD150+CD48− cells into le-
thally irradiated recipient mice in a competitive reconstitution assay
led to long-term multilineage reconstitution by donor cells in nine
of 14 mice (blue lines) and no reconstitution in five of 14 mice
(green lines).esis. To address this, we have examined the spleens of
cyclophosphamide/G-CSF-mobilized mice. CD150+
CD48−CD41− cells were mainly associated with sinusoi-
dal endothelium in parafollicular areas (red pulp) of the
mobilized spleen. To be sure that rare differentiated
cells could not appear to be CD150+CD48−CD41− by
immunohistochemistry, we further stained these cells
with lineage markers (Gr-1, Mac-1, B220, CD2, CD3,
CD4, and CD8) to exclude myeloid, B, and T cells. Only0.0059% ± 0.005% of cells in sections were
CD150+CD48−CD41−Lineage− (identified by scanning
633,000 cells in sections from three independent
spleens; a frequency comparable to that detected by
flow cytometry), and all of these were found in the para-
follicular red pulp. Moreover, these cells expressed
Sca-1 and CD45, just like the CD150+CD48−CD41− cells
identified by flow cytometry (Figure S3). Of the 37
CD150+CD48−CD41−Lineage− cells that were observed,
23 (62%) were in contact with sinusoidal endothelial
cells (Figure 6A). Another 14 CD150+CD48−CD41−Line-
age− cells (38%) were not visibly in contact with endo-
thelium, though they were always near (<10 cell diame-
ters) sinusoids in the red pulp (Figure 6B). Compared
to other cells in red pulp, CD150+CD48−CD41−Lineage−
cells were more than 3-fold more likely to be in contact
with sinusoids, as 18.2% ± 2.2% of all nucleated cells
in the red pulp were in contact with sinusoids. The pro-
portion of cells associated with sinusoids in white pulp
was much lower. These data suggest that most HSCs
within the mobilized spleen are associated with sinusoi-
dal endothelium.
Bone Marrow HSCs Associate with Sinusoidal
Endothelium in Addition to Endosteum
We observed a total of 35 CD150+CD48−CD41−
Lineage− cells in sections from three femurs. These
cells represented 0.0067% ± 0.0016% of cells in the
sections (identified by scanning 522,000 cells in sec-
tions from three independent bones; a frequency com-
parable to that detected by flow cytometry). As in the
spleen, the CD150+CD48−CD41−Lineage− cells iden-
tified in sections expressed Sca-1 and CD45 (Figure
S3). Most of these cells (20 of 35; 57%) were located in
the trabecular zone, and the remaining cells were dis-
tributed throughout the diaphysis (shaft). Five of the
cells (14%) were associated with endosteum, consis-
tent with prior studies (Zhang et al., 2003; Arai et al.,
2004; Wilson et al., 2004), and another nine cells were
not associated with recognizable cell types. Most of the
CD150+CD48−CD41−Lineage− cells that we observed
(21 of 35; 60%) were in contact with sinusoidal endo-
thelium (Figure 6C). Only 10.1% ± 1.4% of all nucleated
bone marrow cells were in contact with sinusoids, indi-
cating that CD150+CD48−CD41−Lineage− cells were
6-fold more likely to contact sinusoids. These data may
underestimate the fraction of HSCs near endosteum
because a minority of bone fragments peeled away
from slides after sectioning, raising the possibility that
some HSCs may have been lost. Nonetheless, many
HSCs appear to localize to sinusoidal endothelium.
Discussion
By comparing the gene expression profiles of highly
purified Thy-1loSca-1+Lineage−c-kit+ HSCs (Table S1),
Thy-1loSca-1+Mac-1loCD4lo MPPs (Table S2), and
CD45+ bone marrow cells, we found that SLAM family
receptors were differentially expressed among hemato-
poietic stem and progenitor cells. CD150 was ex-
pressed by HSCs but not by MPPs or restricted
hematopoietic progenitors (Figures 1 and 3). CD244
was expressed by MPPs and by some restricted pro-
Cell
1116Table 2. Competitive Reconstitution of Irradiated Mice with Single Cells from Various HSC Populations Reveals that Diverse HSC
Populations Are Able to Engraft with High Efficiency in Lethally Irradiated Mice
Engrafted Mice with Cells that Long-Term
Long-Term Multilineage Multilineage
HSC Population Experiment Cells that Engrafted Reconstitution Reconstituted
BM CD150+CD48−Sca-1+Lineage− c-kit+ 1 67% (ten of 15) 70% (seven of 10) 47% (seven of 15)
2 67% (six of nine) 66% (four of six) 44% (four of nine)
3 44% (eight of 18) 88% (seven of eight) 39% (seven of 18)
4 53% (eight of 15) 88% (seven of eight) 47% (seven of 15)
5 58% (seven of 12) 100% (seven of seven) 58% (seven of 12)
Mean ±SD 58% ± 10% 82% ± 14% 47% ± 7% (one in 2.1)
BM CD150+CD48−CD41− 1 30% (three of 10) 100% (three of three) 30% (three of ten)
2 100% (five of five) 60% (three of five) 60% (three of five)
Mean 65% 80% 45% (one in 2.2)
Mobilized spleen CD150+CD48−CD41− 1 42% (five of 12) 80% (four of five) 33% (one in 3.0)
Single cells were sorted into different wells of 96 well plates, and the wells were visually inspected to confirm that only a single cell was
sorted (see Figure S1). Then the contents of each well were individually injected along with 300,000 recipient CD150− bone marrow cells.genitors but not by HSCs (Figure 2). CD48 was ex- v
kpressed by restricted B lineage and myeloerythroid lin-
feage progenitors but not by multipotent progenitors
t(Figure 3). This demonstrates that SLAM family mem-
sbers are differentially expressed among hematopoietic
tprogenitors in a way that correlates with primitiveness.
nThis is the first example of a single family of cell surface
Hreceptors that is precisely differentially expressed
pamong stem and progenitor cells in a way that predicts
developmental potential.
p
O
Improving HSC Purification f
SLAM family members are so precisely differentially ex- l
pressed that HSCs are very highly enriched within the b
CD150+CD48− cell population, which represents only t
0.0084% ± 0.0028% of C57BL bone marrow cells (Fig- 1
ure 4). Twenty-one percent of CD150+CD48− cells (one (
in 4.8) that were intravenously injected into irradiated l
mice gave long-term multilineage reconstitution in limit e
dilution reconstitution assays (Table S5). This demon- h
strates that two SLAM family markers yield HSC enrich-
ments that are comparable to much more complex d
combinations of markers (Morrison et al., 1995; Span- p
grude et al., 1995; Osawa et al., 1996; Wagers et al., c
2002; Benveniste et al., 2003; Chen et al., 2003). More- t
over, 47% of single CD150+CD48−Sca-1+Lineage− o
c-kit+cells (one in 2.1) and 45% of single CD150+CD48− l
CD41− cells (one in 2.2) yield long-term multilineage c
reconstitution in irradiated mice (Table 2). SLAM family f
markers simplify and enhance HSC purification and are W
conserved among mouse strains (Figure 5). o
Most of the best protocols for HSC isolation yield r
populations from which 20% of intravenously injected n
cells engraft and give long-term multilineage reconsti- a
tution (Morrison et al., 1995; Spangrude et al., 1995; H
Osawa et al., 1996; Wagers et al., 2002; Benveniste et
al., 2003; Chen et al., 2003). This raised the question of g
whether the maximum efficiency with which HSCs are a
able to engraft after intravenous transplantation is only t
around 20% (one in five) or whether available markers p
only yield populations of HSCs that are 20% pure (Ben- m
veniste et al., 2003). Recently, HSC purities of 40%– n
t96% were achieved by gating more restrictively on pre-iously identified markers (Matsuzaki et al., 2004; Ta-
ano et al., 2004). However, many HSCs are excluded
rom these very restrictive gates, raising the possibility
hat highly efficient engraftment is a property of only a
ubset of HSCs (Christopherson et al., 2004). The fact
hat we have achieved 47% functional HSC purity using
ew markers that include most or all bone marrow
SCs suggests that highly efficient engraftment is a
roperty of nearly all HSCs in young adult bone marrow.
The ability of SLAM family members to improve HSC
urity is even more dramatic in the mobilized spleen.
nly 1% of Thy-1loSca-1+Lin−c-kit+ cells (one in 100)
rom cyclophosphamide/G-CSF-mobilized spleen give
ong-term multilineage reconstitution, raising the possi-
ility that mobilized HSCs might engraft less efficiently
han HSCs from normal bone marrow (Morrison et al.,
997c). The fact that 33% of CD150+CD48−CD41− cells
one in 3.0) from the mobilized spleen were able to give
ong-term multilineage reconstitution indicates that
ven mobilized HSCs are able to reconstitute with
igh efficiency.
We have not yet detected an HSC defect in CD150-
eficient mice (Wang et al., 2004). Hematopoiesis ap-
eared normal in CD150−/− mice, as the cellularity and
omposition of the bone marrow, blood, spleen, and
hymus were grossly normal (Figure S4A). We did not
bserve any differences between CD150−/− mice and
ittermate controls in terms of complete blood cell
ounts (data not shown) or the frequency of colony-
orming progenitors in the bone marrow (Figure S4B).
e also did not detect any difference in HSC frequency
r reconstituting potential upon transplantation into ir-
adiated mice (Figures S4C and S4D). Thus CD150 is
ot required for HSC maintenance or function in young
dult mice but could regulate more subtle aspects of
SC function.
The mechanism by which the tandemly arrayed
enes at the SLAM locus are differentially expressed
mong primitive hematopoietic progenitors is uncer-
ain. Loss of CD150 did not detectably affect the ex-
ression pattern of CD48 or CD244 on HSCs or on bone
arrow as a whole (data not shown). Thus CD150 did
ot appear to repress CD48 or CD244. Understanding
he mechanisms responsible for the differential expres-
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1117Figure 5. Balb/c and DBA/2 HSCs Are Enriched in the CD150+CD48− Population
CD150+CD48− cells are rare in Balb/c (A) and DBA/2 (B) bone marrow. Ten CD150+CD48− cells from male donors were injected into lethally
irradiated female recipients in competitive reconstitution assays. At week 16, DNA from peripheral leukocytes was extracted and subjected
to qPCR using primers specific for genomic SRY to determine the relative contribution of male cells to the peripheral blood of female
recipients. Control DNA from untreated male mice was diluted into control DNA from untreated female mice as indicated (C and D) to
construct a standard curve. DNA content was normalized based on genomic β-actin amplification (C), and the level of male DNA (SRY) in
each sample was determined by qPCR (D). Eleven out of 16 Balb/c recipients were clearly reconstituted by male cells ([E]; 14 mice are
shown). Seven out of 15 DBA/2 recipients were clearly reconstituted by male cells ([F]; 14 mice are shown). Splenic myeloid (Mac-1+B220-
CD3−), B (B220+CD3−Mac-1−), and T (CD3+Mac-1−B220−) cells were isolated and examined for donor cell chimerism in three reconstituted
mice and one unreconstituted mouse from each strain. In each case, the reconstituted mice showed multilineage reconstitution.sion of SLAM genes might provide important insights
into the determination of stem cell identity, given that
SLAM receptors are differentially expressed in a way
that correlates with primitiveness.
Identifying HSC Niches in Tissue Sections
The identification of a simple combination of markers
that includes most or all HSCs made it possible for the
first time to examine HSC localization in bone marrow
and in extramedullary tissues using markers that were
validated in functional assays to yield high HSC purity.Many HSCs appeared to be in contact with sinusoidal
endothelium in bone marrow, while other HSCs ap-
peared to be associated with endosteum (Figure 6C).
The precise proportion of bone marrow HSCs in each
location is uncertain, given that half of CD150+CD48−
CD41− cells failed to give long-term multilineage recon-
stitution in irradiated mice. HSCs that localized to end-
osteum were presumably associated with osteoblasts,
consistent with prior studies (Calvi et al., 2003; Zhang
et al., 2003; Arai et al., 2004; Visnjic et al., 2004). Since
bone marrow cells enter circulation through sinusoids,
Cell
1118Figure 6. HSCs Are Associated with Sinusoidal Endothelial Cells in the Spleen and Bone Marrow
In the cyclophosphamide/G-CSF mobilized spleen, CD150+CD48−CD41−Lineage− cells represented 0.0059% ± 0.005% of cells in sections.
Twenty-three of 37 (62%) of these cells were in contact with sinusoidal endothelial cells ([A], arrows; * indicates the sinusoid lumen). Another
38% (14 of 37) of CD150+CD48−CD41−Lineage− cells were located in parafollicular regions that were often near sinusoids but not visibly in
contact ([B], arrow). It is unclear whether these cells are migrating to/from sinusoids or whether there are multiple niches within the spleen.
In normal bone marrow, CD150+CD48−CD41−Lineage− cells represented 0.0067% ± 0.0016% of cells in sections. Some of these cells were
closely associated with endosteum (data not shown). However, most of these cells contacted sinusoidal endothelium ([C], arrow). Note the
large megakaryocyte that was also associated with the sinusoid ([C], arrowhead). These images each represent a single optical section, but
a series of images through each cell is shown in Figure S6. Platelets are evident as red (CD150+) and green (CD41+) specks throughout the
images from spleen.the association of HSCs with sinusoidal endothelium o
cexplains how HSCs could be mobilized into circulation
within minutes of treatment with certain cytokines (Lat-
perveer et al., 1995). Bone marrow HSCs appear to lo-
calize to at least two distinct niches, defined by the n
sassociation of HSCs with sinusoidal endothelial cells
and endosteum in different locations within the bone f
imarrow.
We found no heterogeneity within the CD150+ p
pCD48−CD41− HSC population that correlated with the
difference in localization. For example, only 3.8% of d
iCD150+CD48−CD41− cells in normal bone marrow were
in S/G2/M phases of the cell cycle (Figure S5), consis- b
Htent with previous studies reporting that HSCs are
mainly quiescent (Morrison and Weissman, 1994; Ches- d
1hier et al., 1999). This means that the vast majority of
CD150+CD48−CD41− cells associated with both sinus- Lids and endosteum must be in the G0/G1 phase of the
ell cycle.
HSCs in the spleens of mice treated with cyclophos-
hamide/G-CSF appeared to usually associate with si-
usoidal endothelium as well (Figure 6A). However,
ince two-thirds of single CD150+CD48−CD41− cells
ailed to give long-term multilineage reconstitution in
rradiated mice, it is not possible to infer the precise
roportion of HSCs associated with sinusoids as com-
ared to other sites. These results suggest that sinusoi-
al endothelial cells create a niche that sustains HSCs
n extramedullary tissues. These HSCs are unlikely to
e migrating into circulation because the number of
SCs in the spleen continues to increase for several
ays after the onset of mobilization (Morrison et al.,
997c). Moreover, most of the CD150+CD48−CD41−
ineage− cells we observed in normal adult bone mar-
SLAM Receptors Identify Stem Cells and Niches
1119row were also in contact with endothelial cells. The as-
sociation of many HSCs with sinusoidal endothelium
during steady-state hematopoiesis suggests that this
is not a transient interaction.
The observation that HSCs interact with sinusoidal
endothelial cells in bone marrow and extramedullary
tissues is consistent with observations that endothelial
cells express factors that regulate HSC maintenance
and function. Definitive HSCs first arise during embry-
onic development among endothelial cells in the dorsal
aorta and have a very close developmental relationship
with the endothelial lineage (Kennedy et al., 1997; North
et al., 2002; Oberlin et al., 2002; Kubo and Alitalo, 2003).
Coculture of HSCs with vascular endothelial cells from
hematopoietic and nonhematopoietic tissues maintains
the repopulating capacity of HSCs under conditions in
which HSCs would otherwise differentiate or die (Car-
dier and Barbera-Guillem, 1997; Ohneda et al., 1998; Li
et al., 2004). This indicates that endothelial cells ex-
press factors that promote the maintenance of HSCs.
Endothelial cells appear to regulate the function of
primitive hematopoietic progenitors via multiple mech-
anisms in vivo (Heissig et al., 2002; Avecilla et al., 2004).
These observations suggest that endothelial cells cre-
ate a niche in hematopoietic tissues that sustains a
substantial fraction of the HSC pool.
Neural stem cells are also thought to localize to vas-
cular niches (Palmer et al., 2000; Capela and Temple,
2002; Louissaint et al., 2002), and endothelial cells can
support the self-renewal of neural stem cells in culture
(Shen et al., 2004). This raises the possibility that endo-
thelial cells are generally important in the construction
of mammalian stem cell niches and that sinusoidal en-
dothelium represents a specialization adapted for the
maintenance of HSCs.
SLAM family markers represent an important new re-
source for studying HSC biology. The use of SLAM
markers in future studies should refine our understand-
ing of stem cell identity and the role of the environment
in regulating HSC function in vivo.
Experimental Procedures
All mice used in this study were housed in the Unit for Laboratory
Animal Medicine at the University of Michigan. Donor hematopoi-
etic cells were obtained from adult (6- to 8-week-old) C57BL/Ka-
CD45.2:Thy-1.1 mice. Recipient mice in reconstitution assays were
adult C57BL/Ka-CD45.1:Thy-1.2 mice.
Flow-Cytometric Isolation of Stem and Progenitor Cells
Bone marrow cells were flushed from the long bones with Hank’s
buffered salt solution without calcium or magnesium, supple-
mented with 2% heat-inactivated calf serum (GIBCO, Grand Island,
New York; HBSS+). Cells were triturated and filtered through nylon
screen (45 m, Sefar America, Kansas City, Missouri) to obtain a
single cell suspension.
Thy-1loSca-1+Lineage−c-kit+ HSC and Thy-1loSca-1+Mac-1lo
CD4loB220− MPPs were isolated as previously described (Morrison
and Weissman, 1994; Morrison et al., 1997b). For isolation of Thy-1lo
Sca-1+Lineage−c-kit+ cells, whole bone marrow cells were incu-
bated with unconjugated monoclonal antibodies to lineage markers
including B220 (6B2), CD3 (KT31.1), CD5 (53-7.3), CD8 (53-6.7),
Gr-1 (8C5), and Ter119. Following dilution, pelleted cells were re-
suspended in anti-rat IgG-specific F(ab)2 conjugated to phycoer-
ythrin (PE; Jackson ImmunoResearch, West Grove, Pennsylvania).
Cells were then stained with directly conjugated antibodies to
Sca-1 (Ly6A/E-APC), c-kit (2B8-biotin), Thy-1.1 (19XE5-FITC), Mac-1(M1/70-PE), and CD4 (GK1.5-PE). Progenitors were often enriched
by preselecting for Sca-1+ or c-kit+ cells using paramagnetic micro-
beads (Miltenyi Biotec, Auburn, California) and autoMACS. For
isolation of Thy-1loSca-1+Mac-1loCD4loB220− MPPs, the directly
conjugated antibodies described above were combined with anti-
B220-Tricolor (6B2, Caltag, Burlingame, California).
Cells sorted based on CD150 expression were incubated with
unconjugated antibody to CD150 (26D12; DNAX, Palo Alto, Cali-
fornia) and subsequently stained with goat anti-rat IgG F(ab)2 frag-
ment conjugated to FITC, PE, or APC (Jackson ImmunoResearch).
When CD150 was combined with lineage markers, directly conju-
gated antibodies were used to stain lineage markers. Cells sorted
according to CD41, CD48, or CD244 expression were stained with
directly conjugated anti-CD41 (MWReg30-FITC) or anti-CD48
(HM48-1-FITC or PE) or with directly conjugated CD244.2 (2B4-
FITC). Cells were resuspended in 2 g/ml 7-AAD (Molecular
Probes) or DAPI to discriminate live from dead cells. All flow cyto-
metry was performed on a FACS Vantage dual laser flow cytometer
(Becton-Dickinson, San Jose, California).
Long-Term Competitive Reconstitution Assays
Adult recipient mice were irradiated with an Orthovoltage X-ray
source delivering approximately 300 rad/min. C57BL and DBA/2
recipient mice received two doses of 550–570 rad, delivered at
least 2 hr apart. Balb/c recipients received two doses of 495rad.
When HSCs/MPPs were tested for reconstituting potential, the do-
nor (CD45.2+) population was sorted, and the number of cells to be
injected per mouse was resorted into individual wells of a 96-well
plate containing 200,000 CD45.1+ whole bone marrow cells in
HBSS+. The contents of individual wells were injected into the ret-
roorbital venous sinus of individual lethally irradiated CD45.1+ re-
cipients. For at least 16 weeks after transplantation, blood was
obtained from the tail veins of recipient mice, subjected to ammo-
nium-chloride potassium red cell lysis (Morrison and Weissman,
1994), and stained with directly conjugated antibodies to CD45.2
(104, FITC), B220 (6B2), Mac-1 (M1/70), CD3 (KT31.1), and Gr-1
(8C5) to monitor engraftment.
Immunofluorescence Analysis of Hematopoietic Tissue Sections
Femurs from 6- to 12-week-old wild-type mice were embedded in
8% gelatin (Sigma) in phosphate buffer and snap frozen in −80°C
N-methylbutane chilled in a slurry of ethanol and dry ice. Sections
(7 m) were generated using the CryoJane system (Instrumedics,
Hackensack, New Jersey) with coated slides and a tungsten car-
bide blade. Details of the staining procedure can be found in
Supplemental Experimental Procedures. To obtain spleens from
cyclophosphamide/G-CSF-mobilized mice, mice were injected in-
traperitoneally with 4 mg of cyclophosphamide (w200 mg/kg; Bris-
tol-Myers Squibb) and then on successive days with 5 g of human
G-CSF by subcutaneous injection (w250 g/kg per day; Amgen
Biologicals). Mice were sacrificed after 4 days of G-CSF treatment,
and their spleens were dissected, sectioned, and fixed.
RNA Amplification for Microarray Analysis
RNA extraction, amplification, and microarray analysis were per-
formed as described (Iwashita et al., 2003). See Supplemental Ex-
perimental Procedures for details.
Supplemental Data
Supplemental data include six figures, five tables, Supplemental
Experimental Procedures, and Supplemental References and can
be found with this article online at http://www.cell.com/cgi/content/
full/121/7/1109/DC1/.
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